Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Income towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesResearch & DevelopmentShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Intelligent Bio Solutions (INBS) Shares Outstanding (Weighted Average) (2019 - 2025)

Intelligent Bio Solutions has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $1.6 million for Q2 2024.

  • For Q2 2024, Shares Outstanding (Weighted Average) rose 1802.54% year-over-year to $1.6 million; the TTM value through Jun 2024 reached $1.6 million, up 1802.54%, while the annual FY2024 figure was $1.6 million, 1802.54% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q2 2024 was $1.6 million at Intelligent Bio Solutions, down from $2.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $14.9 million in Q3 2022 and troughed at $75690.0 in Q4 2022.
  • A 5-year average of $5.0 million and a median of $1.8 million in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 98.7% in 2023 and later soared 2151.2% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $8.6 million in 2020, then crashed by 91.37% to $744126.0 in 2021, then plummeted by 89.83% to $75690.0 in 2022, then surged by 655.62% to $571930.0 in 2023, then surged by 178.49% to $1.6 million in 2024.
  • Business Quant data shows Shares Outstanding (Weighted Average) for INBS at $1.6 million in Q2 2024, $2.1 million in Q1 2024, and $571930.0 in Q4 2023.